Phase I/II Study of Cabozantinib Alone or in Combination with Panitumumab in Patients with MET -Amplified Metastatic Colorectal Cancer.
Journal of Clinical Oncology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined